Palisade Bio (PALI) Other Operating Expenses (2010 - 2026)

Palisade Bio (PALI) has 10 years of Other Operating Expenses data on file, last reported at -$3.8 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 183.67% year-over-year to -$3.8 million in Q1 2026; TTM through Mar 2026 was -$10.1 million, a 84.51% decrease from a year earlier, with the FY2025 full-year figure at -$7.6 million, down 38.37% from the prior year.
• Other Operating Expenses for Q1 2026 stood at -$3.8 million, down from -$3.6 million in the prior quarter.
• Over the last five years, Other Operating Expenses for PALI reached as high as $12.5 million in Q4 2024 and fell as low as -$15.1 million in Q3 2024.
• Historically, Other Operating Expenses has averaged -$1.4 million across 5 years, with a median of -$1.4 million in 2024.
• Across the five-year window, Other Operating Expenses soared 911.35% in 2024 and plunged 183.67% in 2026, its largest moves.
• Year by year, Other Operating Expenses stood at $410000.0 in 2022, then soared by 200.98% to $1.2 million in 2023, then surged by 911.35% to $12.5 million in 2024, then plunged by 128.61% to -$3.6 million in 2025, then declined by 7.03% to -$3.8 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$3.8 million in Q1 2026, -$3.6 million in Q4 2025, and -$1.5 million in Q3 2025.